Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading on Wednesday. Stock traders acquired 1,885 put options on the stock. This represents an increase of 1,101% compared to the average daily volume of 157 put options.

Evelo Biosciences Price Performance

The company’s 50-day moving average is $0.03 and its two-hundred day moving average is $0.04. The stock has a market capitalization of $2,000.00, a price-to-earnings ratio of 0.00 and a beta of 1.58. Evelo Biosciences has a one year low of $0.00 and a one year high of $13.93.

Institutional Investors Weigh In On Evelo Biosciences

A hedge fund recently raised its stake in Evelo Biosciences stock. Vanguard Group Inc. grew its stake in shares of Evelo Biosciences, Inc. (NASDAQ:EVLO) by 129.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 357,711 shares of the company’s stock after acquiring an additional 201,815 shares during the period. Vanguard Group Inc. owned about 1.88% of Evelo Biosciences worth $1,402,000 at the end of the most recent quarter. 0.31% of the stock is owned by institutional investors and hedge funds.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.